Bio-Rad Laboratories Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio5.284.55
Forward P/E28.8526.5128.6659.8751.81
P/S Ratio3.583.524.457.686.81
P/B Ratio1.401.071.301.641.76
Price/Tangible Book1.571.171.401.721.85
Price/FCF31.7143.08152.7041.8836.41
Price/OCF20.1725.0764.1033.5229.65
PEG Ratio2.712.712.714.2812.95
Enterprise Value Ratios
EV/Revenue3.493.394.287.306.61
EV/EBITDA21.2718.7019.3430.3730.07
EV/EBIT33.2626.7824.8437.7739.96
EV/FCF30.9041.46146.9339.8135.34
Profitability & Returns
Return on Equity (ROE)-0.24%-0.07%-0.31%0.36%0.49%
Return on Assets (ROA)0.02%0.02%0.02%0.02%0.03%
Return on Invested Capital (ROIC)0.04%0.04%0.04%0.04%0.05%
Return on Capital Employed (ROCE)0.03%0.03%0.04%0.03%0.03%
Leverage & Solvency Ratios
Debt/Equity0.210.160.140.020.02
Debt/EBITDA2.802.572.050.300.37
Debt/FCF4.756.4417.010.420.47
Liquidity Ratios
Current Ratio6.485.835.552.923.39
Quick Ratio4.554.034.041.902.24
Efficiency Ratios
Asset Turnover0.240.210.180.190.24
Inventory Turnover1.541.661.912.111.88
Yield & Distribution Ratios
Earnings Yield-0.20%-0.07%-0.29%0.19%0.22%
FCF Yield0.03%0.02%0.01%0.02%0.03%
Buyback Yield0.03%0.02%0.01%0.00%0.00%